Strattera for Attention-Deficit/Hyperactivity Disorder
Strattera (Atomoxetine) is FDA-approved for Attention-Deficit/Hyperactivity Disorder. In short-term studies, most people on atomoxetine had a noticeable reduction in ADHD symptoms compared with those on placebo, though the onset is slower and average effect is a bit smaller than with stimulants. It is still a good option when stimulants aren’t tolerated, don’t work, or aren’t appropriate. This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.
Quick Answer
Strattera (Atomoxetine) is FDA-approved for Attention-Deficit/Hyperactivity Disorder. In short-term studies, most people on atomoxetine had a noticeable reduction in ADHD symptoms compared with those on placebo, though the onset is slower and average effect is a bit smaller than with stimulants. It is still a good option when stimulants aren’t tolerated, don’t work, or aren’t appropriate.
⚠️Important Medical Information
This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.
- This is not medical advice.
- Individual circumstances may vary.
- Always consult your healthcare provider before making treatment decisions.
- Information may not reflect the most recent updates or research.
What is Strattera?
Atomoxetine (brand name Strattera, plus multiple generics) is a non-stimulant medicine for ADHD in kids, teens, and adults. It works differently from stimulants like methylphenidate or amphetamine and has no known abuse or addiction potential. It is usually used when stimulants cause too many side effects, don’t work well enough, or are not a good fit (for example, in people with tics or a history of substance misuse). You take atomoxetine as a capsule once or twice a day. It does not work instantly—symptoms often improve gradually over a few weeks. Common side effects include upset stomach, decreased appetite, nausea, dry mouth, trouble sleeping, and feeling tired or dizzy. It can raise blood pressure and heart rate a little, so vitals need to be checked regularly. There are some important warnings: atomoxetine can increase suicidal thoughts in a small number of children and teens, especially in the first month of treatment, so close monitoring by family and clinicians is essential. Rarely, it can seriously injure the liver (yellow eyes/skin, dark urine, severe fatigue) or cause significant heart problems in people with underlying heart disease. Any major mood changes, suicidal thoughts, chest pain, fainting, or signs of liver trouble should be reported immediately. Atomoxetine is not approved to treat depression.
How Strattera Works for Attention-Deficit/Hyperactivity Disorder
Strattera belongs to the Selective Norepinephrine Reuptake Inhibitor (NRI) class. Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike stimulants, it has no abuse potential and is not a controlled substance
📊How Effective Is It?
In short-term studies, most people on atomoxetine had a noticeable reduction in ADHD symptoms compared with those on placebo, though the onset is slower and average effect is a bit smaller than with stimulants. It is still a good option when stimulants aren’t tolerated, don’t work, or aren’t appropriate.
Clinical Trial Data
ADHD symptom reduction vs placebo: Meaningful response in a substantial proportion of patients. Across multiple 6–18 week randomized trials in children, adolescents, and adults, atomoxetine produced significantly greater reductions in standardized ADHD rating scale scores vs placebo, with moderate effect sizes. It is generally somewhat less potent and slower-acting than stimulants but clinically useful, particularly when stimulants are not an option.
What to Expect: Timeline
Here's the typical timeline when starting Strattera for Attention-Deficit/Hyperactivity Disorder:
- Week 1-2: Initial adjustment period. You may experience temporary side effects like nausea, headache, or sleep changes. These usually improve.
- Week 2-4: Early signs of improvement may appear. Some people notice better sleep, reduced physical symptoms, or slightly improved mood.
- Week 4-8: Therapeutic effects typically become noticeable.
- Week 8-12: Full therapeutic effect. This is when you and your doctor can best assess if the treatment is working.
- Ongoing: Regular follow-up appointments help optimize dosing and monitor progress.
Dosage Information
Strattera dosing for Attention-Deficit/Hyperactivity Disorder is individualized based on response and tolerability.
- Onset: Clinical benefit appears gradually over 1–4 weeks; full effect often requires 4–8 weeks.
- Duration: With a half-life of Atomoxetine ~5 hours in extensive metabolizers; up to ~24 hours in CYP2D6 poor metabolizers., once-daily dosing is typical.
- With food: High-fat meals delay Tmax by ~3 hours but do not meaningfully change overall exposure.
⚠️Common Side Effects
Like all medications, Strattera can cause side effects. Most are mild and improve over time.
- Nausea or upset stomach (usually improves in 1-2 weeks)
- Headache
- Sleep changes (drowsiness or insomnia)
- Fatigue or low energy initially
- Sexual side effects (discuss with your doctor)
⚠️Important Precautions
Discuss with your healthcare provider if any of these apply to you:
- Hypersensitivity to atomoxetine or any component of the formulation
- Use with or within 14 days of a monoamine oxidase inhibitor (MAOI)
- Narrow-angle glaucoma
- Current or history of pheochromocytoma
- Severe cardiac or vascular disorders in which clinically important increases in blood pressure (eg, 15–20 mm Hg) or heart rate (eg, 20 beats/min) would be expected to worsen the condition
- Canadian labeling: symptomatic cardiovascular disease, moderate to severe hypertension, advanced arteriosclerosis, uncontrolled hyperthyroidism
💡Lifestyle Changes That Boost Results
Combining Strattera with these lifestyle changes can improve outcomes:
- Regular physical activity
- Structured routines and organizational systems
- Consistent sleep schedule
- Balanced diet; limit sugar and caffeine
- Mindfulness and relaxation practices
- Use of timers, reminders, and planners
Frequently Asked Questions
How long does Strattera take to work for Attention-Deficit/Hyperactivity Disorder?
Most people notice initial improvements in 2-4 weeks, with full therapeutic effects by 6-8 weeks. Clinical benefit appears gradually over 1–4 weeks; full effect often requires 4–8 weeks.
What is the typical Strattera dosage for Attention-Deficit/Hyperactivity Disorder?
Dosing is individualized based on response and tolerability. Your doctor will typically start at a lower dose and adjust as needed. Never change your dose without medical guidance.
Is Strattera effective for Attention-Deficit/Hyperactivity Disorder?
In short-term studies, most people on atomoxetine had a noticeable reduction in ADHD symptoms compared with those on placebo, though the onset is slower and average effect is a bit smaller than with stimulants. It is still a good option when stimulants aren’t tolerated, don’t work, or aren’t appropriate.
Can I drink alcohol while taking Strattera?
It's generally recommended to avoid or limit alcohol while taking Strattera. Alcohol can worsen Attention-Deficit/Hyperactivity Disorder symptoms and may interact with the medication.
What are the side effects of Strattera?
Common side effects include nausea, headache, sleep changes, and fatigue—most improve in 1-2 weeks. Sexual side effects may persist. Report any concerning symptoms to your doctor.
Is Strattera addictive?
Strattera is not considered addictive in the traditional sense. However, stopping suddenly can cause withdrawal symptoms, so always taper off gradually under medical supervision.
Related Guides
Learn more about Attention-Deficit/Hyperactivity Disorder
Comprehensive guide to symptoms, causes, and all treatment options
Full Strattera guide
Complete medication information, dosing, and precautions
Strattera side effects
Detailed guide to common and serious side effects
Attention-Deficit/Hyperactivity Disorder treatment options
Compare all available treatments
Medically Reviewed
Last reviewed: January 2025
Reviewed for clinical accuracy against FDA labeling and current practice guidelines.
Information based on:
- FDA prescribing information
- APA practice guidelines
- Peer-reviewed medical literature
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.